FN1 and ovarian carcinoma: These results demonstrated that HK2 could elevate Akt1 and p-Akt1 expression in human ovarian cancer cells, subsequently enhancing cell motility by inducing Fibronectin and MMP9 expression, promoting cell growth by reducing p21 and p27 expression.